Clinical Trial Update: Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating prevention of cardiovascular events with antiplatelet therapy after acute coronary syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome | Status: COMPLETED